Manke Isaac 4
4 · OnKure Therapeutics, Inc. · Filed Oct 8, 2024
Insider Transaction Report
Form 4
Manke Isaac
Director
Transactions
- Award
Stock Option (right to buy)
2024-10-04+15,300→ 15,300 totalExercise: $18.20Exp: 2034-10-03→ Class A Common Stock (15,300 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option shall vest on November 4, 2024 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.